Clicky

Friday, November 20, 2026
All public companies · Official EDGAR

VCNXVACCINEX, INC.

OTC · CIK 0001205922
Filer categoryNon-accelerated filer<br>Smaller reporting company
Entity typeoperating
SIC2834 Pharmaceutical Preparations
FY end1231
XBRL facts221

Identity from submissions API

NameVACCINEX, INC.
CIK0001205922
TickersVCNX
ExchangesOTC
Entity typeoperating
CategoryNon-accelerated filer<br>Smaller reporting company
SIC2834 Pharmaceutical Preparations
EIN161603202
LEI—
Fiscal year end1231
State of incorporationDE DE
Phone585-271-2700
Website—
Investor website—
Owner org03 Life Sciences
Flags—
Description—
Insider transactions (issuer)1
Insider transactions (owner)1

Former names

  • VACCINEX INC (2002-11-12T00:00:00.000Z → 2005-05-09T00:00:00.000Z)
Business address
1895 MOUNT HOPE AVE
ROCHESTER
NY
14620
NY
Mailing address
1895 MOUNT HOPE AVE
ROCHESTER
NY
14620
NY

EDGAR has no company-logo API. Website field is shown when the filer provided one.

Financialist coverage

No Financialist filing articles yet for this CIK.

SEC filings

475 filing rows loaded from submissions recent.

FiledFormDocumentItemsAccessionFile no.FilmActSizeXBRLiXBRL
2025-04-15 10-K 10-K 0000950170-25-054318 001-38624 25840492 34 26812590 1 1
2025-04-01 NT 10-K NT 10-K 0001193125-25-069655 001-38624 25796539 34 23304
2025-03-27 15-12G 15-12G 0001193125-25-064732 001-38624 25775443 34 11260
2025-03-25 EFFECT xslEFFECTX01/primary_doc.xml ,, 9999999995-25-000768 333-282679 25769907 33 1793
2025-03-25 EFFECT xslEFFECTX01/primary_doc.xml ,, 9999999995-25-000765 333-280535 25769904 33 1793
2025-03-25 EFFECT xslEFFECTX01/primary_doc.xml ,, 9999999995-25-000763 333-278968 25769902 33 1793
2025-03-25 EFFECT xslEFFECTX01/primary_doc.xml ,, 9999999995-25-000762 333-278467 25769901 33 1793
2025-03-25 EFFECT xslEFFECTX01/primary_doc.xml ,, 9999999995-25-000761 333-276465 25769900 33 1793
2025-03-25 EFFECT xslEFFECTX01/primary_doc.xml ,, 9999999995-25-000758 333-274756 25769896 33 1793
2025-03-25 EFFECT xslEFFECTX01/primary_doc.xml ,, 9999999995-25-000757 333-274520 25769894 33 1793
2025-03-25 EFFECT xslEFFECTX01/primary_doc.xml ,, 9999999995-25-000756 333-272649 25769892 33 1793
2025-03-25 EFFECT xslEFFECTX01/primary_doc.xml ,, 9999999995-25-000755 333-271074 25769890 33 1793
2025-03-25 EFFECT xslEFFECTX01/primary_doc.xml ,, 9999999995-25-000754 333-269385 25769888 33 1793
2025-03-25 EFFECT xslEFFECTX01/primary_doc.xml ,, 9999999995-25-000752 333-264236 25769883 33 1793
2025-03-25 EFFECT xslEFFECTX01/primary_doc.xml ,, 9999999995-25-000750 333-246326 25769879 33 1793
2025-03-25 EFFECT xslEFFECTX01/primary_doc.xml ,, 9999999995-25-000749 333-246322 25769877 33 1793
2025-03-25 EFFECT xslEFFECTX01/primary_doc.xml ,, 9999999995-25-000747 333-236417 25769873 33 1793
2025-03-25 EFFECT xslEFFECTX01/primary_doc.xml ,, 9999999995-25-000746 333-233607 25769870 33 1793
2025-03-25 POS AM POS AM 0001193125-25-062021 333-274756 25766027 33 37989
2025-03-25 POS AM POS AM 0001193125-25-062019 333-274520 25766021 33 37989
2025-03-25 POS AM POS AM 0001193125-25-062017 333-282679 25766014 33 37989
2025-03-25 POS AM POS AM 0001193125-25-062014 333-280535 25766013 33 37989
2025-03-25 POS AM POS AM 0001193125-25-062009 333-278968 25766009 33 37989
2025-03-25 POS AM POS AM 0001193125-25-062006 333-278467 25766006 33 37989
2025-03-25 POS AM POS AM 0001193125-25-062003 333-276465 25766005 33 37989
2025-03-25 POS AM POS AM 0001193125-25-062001 333-272649 25766001 33 37989
2025-03-25 POS AM POS AM 0001193125-25-061999 333-271074 25765999 33 37989
2025-03-25 POS AM POS AM 0001193125-25-061994 333-269385 25765991 33 37989
2025-03-25 POS AM POS AM 0001193125-25-061993 333-264236 25765988 33 37989
2025-03-25 POS AM POS AM 0001193125-25-061992 333-246326 25765986 33 37989
2025-03-25 POS AM POS AM 0001193125-25-061991 333-246322 25765982 33 37989
2025-03-25 POS AM POS AM 0001193125-25-061990 333-236417 25765979 33 37989
2025-03-25 POS AM POS AM 0001193125-25-061989 333-233607 25765973 33 37989
2025-03-25 S-8 POS S-8 POS 0001193125-25-061988 333-279307 25765971 33 19779
2025-03-25 S-8 POS S-8 POS 0001193125-25-061986 333-226964 25765970 33 19779
2025-03-19 8-K 8-K 5.02 0001193125-25-057850 001-38624 25752935 34 140241 1 1
2025-03-17 25 25 0001193125-25-055645 001-38624 25745012 34 11890
2025-03-07 8-K 8-K 3.01,7.01,9.01 0001193125-25-049988 001-38624 25721287 34 159960 1 1
2025-02-14 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0001172661-25-001211 005-90610 25630126 34 10597
2024-12-17 8-K 8-K 3.01,8.01,9.01 0001193125-24-280155 001-38624 241553839 34 161559 1 1
2024-11-18 SC 13D/A SC 13D/A 0001193125-24-260927 005-90610 241471689 34 62432
2024-11-18 4 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES 0001062993-24-019266 15491
2024-11-18 4 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES 0001062993-24-019265 18281
2024-11-14 8-K 8-K 1.01,3.02,9.01 0001193125-24-258757 001-38624 241463986 34 536138 1 1
2024-11-14 10-Q 10-Q 0000950170-24-127139 001-38624 241463644 34 8561233 1 1
2024-11-14 SC 13G armistice-vcnx093024.htm 0001172661-24-005111 005-90610 241461135 34 90554
2024-10-25 424B3 424B3 0001193125-24-244137 333-282679 241397186 33 167116
2024-10-24 EFFECT xslEFFECTX01/primary_doc.xml S-3,,2024-10-24 16:30:00 9999999995-24-003276 333-282679 241393942 33 1788
2024-10-22 CORRESP filename1.htm 0001193125-24-241060 6055
2024-10-21 UPLOAD filename1.pdf 0000000000-24-011780 333-282679 40077
2024-10-16 S-3 S-3 0001193125-24-238151 333-282679 241375096 33 267597
2024-10-09 8-K 8-K 3.01 0001193125-24-235251 001-38624 241363132 34 141967 1 1
2024-09-27 D xslFormDX01/primary_doc.xml 06b 0001123292-24-000293 021-525279 241334978 33 12644
2024-09-20 SC 13D/A SC 13D/A 0001193125-24-222994 005-90610 241314132 34 141067
2024-09-20 SC 13D/A SC 13D/A 0001193125-24-222970 005-90610 241313986 34 69760
2024-09-20 4 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES 0001062993-24-016842 36003
2024-09-20 4 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES 0001062993-24-016838 19757
2024-09-19 8-K 8-K 1.01,3.02,9.01 0001193125-24-221790 001-38624 241309163 34 343196 1 1
2024-09-13 8-K 8-K 5.02 0001193125-24-218870 001-38624 241297950 34 139948 1 1
2024-08-20 8-K 8-K 8.01 0001193125-24-203149 001-38624 241222531 34 141211 1 1
2024-08-14 10-Q 10-Q 0000950170-24-097217 001-38624 241209572 34 7805843 1 1
2024-08-14 8-K 8-K 7.01,9.01 0001193125-24-200272 001-38624 241204374 34 236043 1 1
2024-08-13 4 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES 0001062993-24-014976 13043
2024-08-07 SC 13D/A SC 13D/A 0001193125-24-195887 005-90610 241183845 34 112071
2024-08-07 4 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES 0001062993-24-014577 14575
2024-08-02 4 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES 0001062993-24-014364 13045
2024-08-01 SC 13D/A SC 13D/A 0001193125-24-191522 005-90610 241166832 34 115950
2024-08-01 4 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES 0001062993-24-014289 20967
2024-07-31 8-K 8-K 8.01,9.01 0001193125-24-189569 001-38624 241160042 34 173575 1 1
2024-07-08 424B3 424B3 0001193125-24-176303 333-280535 241104911 33 152747
2024-07-05 EFFECT xslEFFECTX01/primary_doc.xml S-3,,2024-07-05 16:30:00 9999999995-24-002085 333-280535 241103265 33 1788
2024-07-02 CORRESP filename1.htm 0001193125-24-174355 6971
2024-07-01 UPLOAD filename1.pdf 0000000000-24-007473 333-280535 40054
2024-06-27 S-3 S-3 0001193125-24-170651 333-280535 241079841 33 254115
2024-06-06 8-K 8-K 7.01,9.01 0001193125-24-155612 001-38624 241023913 34 176379 1 1
2024-05-31 4 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES 0001062993-24-011556 18186
2024-05-15 10-Q 10-Q 0000950170-24-060603 001-38624 24952687 34 9041545 1 1
2024-05-14 4/A AMENDED STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES 0001062993-24-010189 5920
2024-05-14 4/A AMENDED STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES 0001062993-24-010187 5935
2024-05-14 4/A AMENDED STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES 0001062993-24-010186 5961
2024-05-14 4/A AMENDED STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES 0001062993-24-010185 6123
2024-05-14 4 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES 0001062993-24-010184 13676
2024-05-14 4 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES 0001062993-24-010183 20214
2024-05-14 4 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES 0001062993-24-010182 14819
2024-05-14 4 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES 0001062993-24-010181 11013
2024-05-14 4 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES 0001062993-24-010179 40452
2024-05-10 S-8 S-8 0001193125-24-135964 333-279307 24933788 33 80394
2024-05-09 424B3 424B3 0001193125-24-135374 333-278968 24931806 33 171544
2024-05-09 8-K 8-K 5.07 0001193125-24-135285 001-38624 24930900 34 155565 1 1
2024-05-08 EFFECT xslEFFECTX01/primary_doc.xml S-3,,2024-05-08 16:05:00 9999999995-24-001488 333-278968 24936705 33 1787
2024-05-08 S-3/A S-3/A 0001193125-24-133969 333-278968 24925008 33 230333
2024-05-02 CORRESP filename1.htm 0001193125-24-129388 7063
2024-05-02 UPLOAD filename1.pdf 0000000000-24-004979 333-278968 40318
2024-04-26 S-3 S-3 0001193125-24-118410 333-278968 24885292 33 274183
2024-04-25 10-K/A 10-K/A 0000950170-24-048163 001-38624 24875524 34 7450488 1 1
2024-04-22 4 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES 0001062993-24-008643 13042
2024-04-16 EFFECT xslEFFECTX01/primary_doc.xml S-3,,2024-04-16 16:30:00 9999999995-24-000987 333-278467 24849284 33 1787
2024-04-16 424B3 424B3 0001193125-24-097887 333-278467 24848504 33 159061
2024-04-12 CORRESP filename1.htm 0001193125-24-094751 5977
2024-04-12 D xslFormDX01/primary_doc.xml 06b 0001123292-24-000109 021-510534 24841815 33 12398
2024-04-12 D xslFormDX01/primary_doc.xml 06b 0001123292-24-000107 021-510533 24841730 33 12398
2024-04-12 8-K 8-K 3.01 0001193125-24-094701 001-38624 24841705 34 141440 1 1
2024-04-12 D xslFormDX01/primary_doc.xml 06b 0001123292-24-000105 021-510530 24841633 33 13711
2024-04-03 UPLOAD filename1.pdf 0000000000-24-003597 333-278467 40301
2024-04-02 ARS ARS 0001193125-24-084791 001-38624 24814719 34 3544720
2024-04-02 DEF 14A DEF 14A 0001193125-24-084768 001-38624 24814594 34 1025837
2024-04-02 S-3 S-3 0001193125-24-084759 333-278467 24814315 33 267238
2024-04-02 10-K 10-K 0000950170-24-039700 001-38624 24811897 34 21635296 1 1
2024-04-02 NT 10-K NT 10-K 0001193125-24-083757 001-38624 24811862 34 21897
2024-04-01 4 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES 0001062993-24-007661 25572
2024-04-01 4 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES 0001062993-24-007660 14125
2024-04-01 8-K 8-K 1.01,3.02,5.03,9.01 0001193125-24-083568 001-38624 24810694 34 1384509 1 1
2024-03-28 8-K 8-K 8.01,9.01 0001193125-24-080804 001-38624 24800012 34 158924 1 1
2024-03-28 424B5 424B5 0001193125-24-080254 333-271074 24797091 33 318735
2024-03-27 8-K 8-K 8.01 0001193125-24-078295 001-38624 24785941 34 142878 1 1
2024-03-22 4 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES 0001062993-24-006960 15596
2024-03-22 4 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES 0001062993-24-006959 15356
2024-03-22 4 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES 0001062993-24-006958 13540
2024-03-22 4 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES 0001062993-24-006957 22128
2024-03-14 3 INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES 0001062993-24-006424 13122
2024-03-04 8-K 8-K 5.02 0001193125-24-057888 001-38624 24715202 34 141160 1 1
2024-02-21 8-K 8-K 8.01,9.01 0001193125-24-040885 001-38624 24656714 34 171066 1 1
2024-02-15 8-K 8-K 3.03,5.03,8.01,9.01 0001193125-24-037078 001-38624 24642187 34 201463 1 1
2024-02-13 8-K 8-K 5.07 0001193125-24-033801 001-38624 24626570 34 147752 1 1
2024-02-13 SC 13D/A SC 13D/A 0001193125-24-033733 005-90610 24626128 34 134193
2024-02-12 SC 13D/A SC 13D/A 0001193125-24-032098 005-90610 24620289 34 90093
2024-02-09 4 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES 0001062993-24-002770 24430
2024-02-09 4 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES 0001062993-24-002769 12547
2024-02-09 SC 13G VACCINEX, INC. 0000902664-24-001362 005-90610 24614872 34 77268
2024-02-08 8-K/A 8-K/A 9.01 0001193125-24-027618 001-38624 24606953 34 273674 1 1
2024-02-07 SC 13G/A formsc13ga.htm 0001493152-24-005339 005-90610 24606308 34 110772
2024-02-07 8-K 8-K 1.01,3.02,9.01 0001193125-24-026615 001-38624 24604129 34 732871 1 1
2024-01-19 EFFECT xslEFFECTX01/primary_doc.xml S-3,,2024-01-19 09:00:00 9999999995-24-000161 333-276465 24546968 33 1787
2024-01-19 424B3 424B3 0001193125-24-011297 333-276465 24546139 33 198055
2024-01-17 CORRESP filename1.htm 0001193125-24-008940 7226
2024-01-16 UPLOAD filename1.pdf 0000000000-24-000489 333-276465 40303
2024-01-10 S-3 S-3 0001193125-24-006026 333-276465 24527276 33 297528
2024-01-08 DEF 14A DEF 14A 0001193125-24-004424 001-38624 24520328 34 297602
2023-12-28 4 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES 0001062993-23-023239 17480
2023-12-28 PRE 14A PRE 14A 0001193125-23-305168 001-38624 231522873 34 221699
2023-12-12 4 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES 0001062993-23-022436 17602
2023-11-13 10-Q 10-Q 0000950170-23-062454 001-38624 231395160 34 6392292 1 1
2023-11-03 4 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES 0001062993-23-020103 22466
2023-10-26 8-K 8-K 7.01,9.01 0001193125-23-263647 001-38624 231347727 34 168093 1 1
2023-10-25 4 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES 0001062993-23-019700 38026
2023-10-18 SC 13D/A SC 13D/A 0001193125-23-258489 005-90610 231332416 34 233733
2023-10-13 8-K 8-K 3.01,8.01 0001193125-23-256153 001-38624 231325541 34 153167 1 1
2023-10-12 SC 13D/A SC 13D/A 0001193125-23-255043 005-90610 231323048 34 93033
2023-10-11 SC 13G formsc13g.htm 0001493152-23-036885 005-90610 231320032 34 108072
2023-10-05 4 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES 0001062993-23-019063 25868
2023-10-05 4 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES 0001062993-23-019061 11202
2023-10-05 4 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES 0001062993-23-019059 39388
2023-10-04 8-K 8-K 1.01,9.01 0001193125-23-250405 001-38624 231306701 34 688922 1 1
2023-10-02 424B4 424B4 0001193125-23-248527 333-274520 231298125 33 221833
2023-09-28 EFFECT xslEFFECTX01/primary_doc.xml S-1,,2023-09-28 17:00:00 9999999995-23-002823 333-274520 231291640 33 1739
2023-09-28 S-1MEF S-1MEF 0001193125-23-246045 333-274756 231291472 33 99481
2023-09-27 8-K 8-K 7.01 0001193125-23-243082 001-38624 231281854 34 146225 1 1
2023-09-26 SC 13D/A SC 13D/A 0001193125-23-242480 005-90610 231280626 34 59861
2023-09-26 CORRESP filename1.htm 0001193125-23-242068 6783
2023-09-26 CORRESP filename1.htm 0001193125-23-242064 6941
2023-09-26 8-K 8-K 7.01,9.01 0001193125-23-241942 001-38624 231277194 34 270800 1 1
2023-09-26 S-1/A S-1/A 0001193125-23-241928 333-274520 231277188 33 738143
2023-09-25 4 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES 0001062993-23-018438 18205
2023-09-22 8-K 8-K 3.03,5.03,8.01,9.01 0001193125-23-240553 001-38624 231272177 34 192772 1 1
2023-09-22 8-K 8-K 1.01,3.02,9.01 0001193125-23-240513 001-38624 231271968 34 464088 1 1
2023-09-20 UPLOAD filename1.pdf 0000000000-23-010347 40251
2023-09-14 S-1 S-1 0001193125-23-235408 333-274520 231255972 33 357735
2023-09-13 8-K 8-K 5.07 0001193125-23-233884 001-38624 231251579 34 150656 1 1
2023-08-22 8-K 8-K 1.01,3.02,9.01 0001193125-23-218037 001-38624 231193937 34 429950 1 1
2023-08-14 DEF 14A DEF 14A 0001193125-23-212402 001-38624 231170921 34 289908
2023-08-14 10-Q 10-Q 0000950170-23-042073 001-38624 231166405 34 6216003 1 1
2023-08-04 PRE 14A PRE 14A 0001193125-23-203956 001-38624 231144690 34 214328
2023-07-11 424B3 424B3 0001193125-23-184962 333-272649 231081160 33 159361
2023-07-10 EFFECT xslEFFECTX01/primary_doc.xml S-3,,2023-07-10 17:00:00 9999999995-23-002038 333-272649 231081129 33 1739
2023-07-07 CORRESP filename1.htm 0001193125-23-183865 7075
2023-06-20 UPLOAD filename1.pdf 0000000000-23-006574 40222
2023-06-14 S-3 S-3 0001193125-23-166936 333-272649 231014894 33 521135
2023-05-30 8-K 8-K 3.01 0001193125-23-156073 001-38624 23971625 34 145143 1 1
2023-05-25 SC 13D/A SC 13D/A 0001193125-23-154275 005-90610 23961213 34 117616
2023-05-19 8-K 8-K 8.01,9.01 0001193125-23-149499 001-38624 23941484 34 166008 1 1
2023-05-19 424B5 424B5 0001193125-23-149497 333-271074 23941466 33 259323
2023-05-16 4 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES 0001062993-23-011230 8822
2023-05-15 8-K 8-K 1.01,3.02,9.01 0001193125-23-145153 001-38624 23923879 34 344668 1 1
2023-05-15 4 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES 0001062993-23-011116 9375
2023-05-15 4 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES 0001062993-23-011115 35158
2023-05-15 10-Q 10-Q 0000950170-23-022252 001-38624 23923228 34 5554046 1 1
2023-05-15 4 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES 0001062993-23-011112 10722
2023-05-15 4 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES 0001062993-23-011110 12044
2023-05-15 4 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES 0001062993-23-011108 17529
2023-05-12 8-K 8-K 5.07 0001193125-23-142882 001-38624 23913357 34 149856 1 1
2023-04-12 EFFECT xslEFFECTX01/primary_doc.xml S-3,,2023-04-12 16:30:00 9999999995-23-000913 333-271074 23816931 33 1738
2023-04-10 CORRESP filename1.htm 0001193125-23-096533 5905
2023-04-07 UPLOAD filename1.pdf 0000000000-23-003505 40266
2023-04-06 ARS ARS 0001193125-23-093166 001-38624 23804468 34 14088574
2023-04-06 DEF 14A DEF 14A 0001193125-23-093157 001-38624 23804458 34 383710
2023-04-05 SC 13D/A SC 13D/A 0001193125-23-092337 005-90610 23802978 34 132811
2023-04-03 4 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES 0001062993-23-008326 14908
2023-04-03 4 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES 0001062993-23-008325 14257
2023-04-03 4 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES 0001062993-23-008324 34130
2023-04-03 4 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES 0001062993-23-008323 8819
2023-04-03 4 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES 0001062993-23-008322 14210
2023-04-03 4 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES 0001062993-23-008321 12968
2023-04-03 4 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES 0001062993-23-008320 18994
2023-04-03 S-3 S-3 0001193125-23-089051 333-271074 23790938 33 1053795
2023-04-03 8-K 8-K 1.01,3.02,9.01 0001193125-23-089004 001-38624 23790815 34 345063 1 1
2023-03-31 10-K 10-K 0000950170-23-011354 001-38624 23787370 34 14911613 1 1
2023-03-23 8-K 8-K 5.02 0001193125-23-077886 001-38624 23756411 34 145756 1 1
2023-03-09 8-K FORM 8-K 7.01,9.01 0001193125-23-065339 001-38624 23718240 34 172843 1 1
2023-02-01 424B3 424B3 0001193125-23-020775 333-269385 23574633 33 117892
2023-01-31 EFFECT xslEFFECTX01/primary_doc.xml S-3,,2023-01-31 16:30:00 9999999995-23-000245 333-269385 23574596 33 1738
2023-01-27 CORRESP filename1.htm 0001193125-23-017528 5928
2023-01-26 UPLOAD filename1.pdf 0000000000-23-000897 40187
2023-01-24 S-3 S-3 0001193125-23-014055 333-269385 23547099 33 219863
2023-01-04 4 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES 0001062993-23-000300 32883
2022-12-07 4 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES 0001062993-22-023491 16972
2022-11-29 SC 13D/A SC 13D/A 0001193125-22-294363 005-90610 221433190 34 131748
2022-11-28 4 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES 0001062993-22-022815 16958
2022-11-28 4 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES 0001062993-22-022816 8996
2022-11-28 4 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES 0001062993-22-022814 31215
2022-11-28 4 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES 0001062993-22-022813 17232
2022-11-28 SC 13D/A SC 13D/A 0001193125-22-293427 005-90610 221425936 34 62367
2022-11-25 8-K 8-K 1.01,3.02,9.01 0001193125-22-292625 001-38624 221420303 34 468257 1 1
2022-11-14 10-Q 10-Q 0001564590-22-037499 001-38624 221380417 34 6172170 1 1
2022-11-10 8-K 8-K 7.01,9.01 0001193125-22-282054 001-38624 221375238 34 199918 1 1
2022-10-11 8-K 8-K 3.01 0001193125-22-260706 001-38624 221304669 34 145607 1 1
2022-10-03 4 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES 0001062993-22-020146 31658
2022-09-13 8-K 8-K 7.01,9.01 0001193125-22-243745 001-38624 221241122 34 2752614 1 1
2022-08-15 10-Q 10-Q 0001564590-22-029397 001-38624 221162428 34 5788477 1 1
2022-08-08 8-K 8-K 8.01,9.01 0001193125-22-214504 001-38624 221143126 34 182699 1 1
2022-08-01 8-K 8-K 7.01,9.01 0001193125-22-207791 001-38624 221122838 34 10629888 1 1
2022-07-01 4 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES 0001062993-22-015746 30445
2022-06-10 8-K 8-K 7.01,9.01 0001193125-22-171530 001-38624 221007664 34 8885089 1 1
2022-05-17 424B5 424B5 0001193125-22-152570 333-236416 22932491 33 13965
2022-05-16 10-Q 10-Q 0001564590-22-020252 001-38624 22925595 34 5225837 1 1
2022-05-13 4 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES 0001062993-22-012390 7967
2022-05-13 4 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES 0001062993-22-012388 17337
2022-05-13 4 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES 0001062993-22-012386 9314
2022-05-13 4 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES 0001062993-22-012385 10637
2022-05-13 4 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES 0001062993-22-012384 28888
2022-05-13 8-K 8-K 5.07 0001193125-22-150166 001-38624 22923314 34 151867 1 1
2022-04-29 424B3 424B3 0001193125-22-133787 333-264236 22875683 33 160226
2022-04-27 EFFECT xslEFFECTX01/primary_doc.xml S-3,,2022-04-27 16:30:00 9999999995-22-001124 333-264236 22861921 33 1738
2022-04-25 CORRESP filename1.htm 0001193125-22-117561 6484
2022-04-14 UPLOAD filename1.pdf 0000000000-22-004059 40199
2022-04-11 S-3 S-3 0001193125-22-101736 333-264236 22820089 33 268850
2022-04-05 DEF 14A DEF 14A 0001193125-22-095655 001-38624 22805301 34 641041
2022-04-04 4 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES 0001062993-22-009451 12961
2022-04-04 4 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES 0001062993-22-009450 13659
2022-04-04 8-K 8-K 5.02 0001193125-22-095136 001-38624 22802877 34 146319 1 1
2022-04-04 4 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES 0001062993-22-009448 16866
2022-04-04 4 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES 0001062993-22-009446 12567
2022-04-04 4 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES 0001062993-22-009444 11719
2022-04-04 4 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES 0001062993-22-009441 27858
2022-03-31 10-K 10-K 0001564590-22-012778 001-38624 22789359 34 15125171 1 1
2022-03-08 8-K 8-K 5.02 0001193125-22-069387 001-38624 22722564 34 143197 1 1
2022-02-24 4 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES 0001062993-22-005567 17229
2022-02-14 SC 13D/A SC 13D/A 0001193125-22-040223 005-90610 22626817 34 135734
2022-02-10 SC 13D SC 13D 0001193125-22-034655 005-90610 22615313 34 70876
2022-01-31 8-K 8-K 1.01,3.02,8.01,9.01 0001193125-22-023545 001-38624 22575333 34 548760 1 1
2022-01-31 4 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES 0001062993-22-001868 26275
2022-01-31 4 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES 0001062993-22-001867 9869
2022-01-31 4 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES 0001062993-22-001866 15444
2022-01-26 8-K 8-K 8.01,9.01 0001193125-22-017722 001-38624 22555728 34 179604 1 1
2022-01-03 4 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES 0001062993-22-000063 26648
2021-11-08 10-Q 10-Q 0001564590-21-055065 001-38624 211386562 34 6857607 1 1
2021-10-04 4 PRIMARY DOCUMENT 0000891839-21-000316 25511
2021-08-16 10-Q 10-Q 0001564590-21-044453 001-38624 211174602 34 6596599 1 1
2021-08-03 8-K 8-K 1.02 0001193125-21-234931 001-38624 211139766 34 145410 1 1
2021-07-02 4 PRIMARY DOCUMENT 0000891839-21-000247 24055
2021-06-28 4 PRIMARY DOCUMENT 0000891839-21-000234 30987
2021-06-24 4 PRIMARY DOCUMENT 0000891839-21-000232 15349
2021-05-21 3 PRIMARY DOCUMENT 0000891839-21-000168 12072
2021-05-17 8-K 8-K 2.02,5.02,9.01 0001193125-21-162841 001-38624 21927712 34 49054
2021-05-17 10-Q 10-Q 0001564590-21-028189 001-38624 21927650 34 4929235 1
2021-05-12 4 PRIMARY DOCUMENT 0000891839-21-000140 11177
2021-05-12 4 PRIMARY DOCUMENT 0000891839-21-000139 8049
2021-05-12 4 PRIMARY DOCUMENT 0000891839-21-000138 9372
2021-05-12 4 PRIMARY DOCUMENT 0000891839-21-000137 6702
2021-05-12 4 PRIMARY DOCUMENT 0000891839-21-000136 15464
2021-05-12 4 PRIMARY DOCUMENT 0000891839-21-000135 26026
2021-05-12 8-K 8-K 5.07 0001193125-21-159064 001-38624 21915263 34 23616
2021-04-06 DEF 14A DEF 14A 0001193125-21-107654 001-38624 21809572 34 354566
2021-04-02 4 PRIMARY DOCUMENT 0000891839-21-000101 10372
2021-04-02 4 PRIMARY DOCUMENT 0000891839-21-000100 15374
2021-04-02 4 PRIMARY DOCUMENT 0000891839-21-000099 12141
2021-04-02 4 PRIMARY DOCUMENT 0000891839-21-000098 11449
2021-04-01 4 PRIMARY DOCUMENT 0000891839-21-000089 25000
2021-03-31 10-K 10-K 0001564590-21-016874 001-38624 21789877 34 10892279 1
2021-03-25 8-K 8-K 5.02 0001193125-21-094459 001-38624 21772558 34 19043
2021-03-16 8-K 8-K 2.02,9.01 0001193125-21-082168 001-38624 21743669 34 51157
2021-02-19 8-K 8-K 8.01,9.01 0001193125-21-048682 001-38624 21653729 34 31525
2021-02-16 SC 13G/A SCHEDULE 13G (AMENDMENT #1) 0000899140-21-000310 005-90610 21637205 34 41173
2021-02-12 SC 13G/A vaccinex13ga_02102021.htm 0001123292-21-000243 005-90610 21628354 34 246508
2021-01-04 4 PRIMARY DOCUMENT 0000891839-21-000004 23787
2020-12-09 8-K/A 8-K/A 5.02 0001193125-20-313834 001-38624 201378198 34 19585
2020-11-20 10-Q/A 10-Q/A 0001193125-20-298336 001-38624 201329913 34 39850
2020-11-13 10-Q 10-Q 0001564590-20-053729 001-38624 201309170 34 5885279 1
2020-10-26 8-K 8-K 5.02 0001193125-20-276927 001-38624 201260886 34 17544
2020-10-19 SC 13G SCHEDULE 13G 0001104659-20-115880 005-90610 201245478 34 32616
2020-10-01 4 PRIMARY DOCUMENT 0000891839-20-000296 22571
2020-09-22 8-K FORM 8-K 8.01,9.01 0001193125-20-250645 001-38624 201187873 34 34291
2020-09-16 D xslFormDX01/primary_doc.xml 06b 0001567619-20-016794 021-375681 201178999 33 12885
2020-09-09 8-K 8-K 8.01,9.01 0001193125-20-242257 001-38624 201167038 34 33619
2020-09-09 424B5 424B5 0001193125-20-242246 333-236416 201166987 33 443189
2020-09-03 4 PRIMARY DOCUMENT 0000891839-20-000256 9730
2020-09-03 4/A PRIMARY DOCUMENT 0000891839-20-000255 6860
2020-09-01 4 PRIMARY DOCUMENT 0000891839-20-000254 5304
2020-09-01 3 PRIMARY DOCUMENT 0000891839-20-000253 5847
2020-08-27 8-K FORM 8-K 5.02,9.01 0001193125-20-232105 001-38624 201139078 34 30623
2020-08-25 EFFECT xslEFFECTX01/primary_doc.xml S-3,,2020-08-25 16:30:00 9999999995-20-002255 333-246326 201134069 33 1739
2020-08-25 EFFECT xslEFFECTX01/primary_doc.xml S-3,,2020-08-25 16:30:00 9999999995-20-002254 333-246322 201134068 33 1739
2020-08-21 CORRESP filename1.htm 0001193125-20-227003 5617
2020-08-21 CORRESP filename1.htm 0001193125-20-227000 5616
2020-08-21 S-3/A FORM S-3/A 0001193125-20-226994 333-246326 201123512 33 73940
2020-08-20 UPLOAD filename1.pdf 0000000000-20-007747 40154
2020-08-20 UPLOAD filename1.pdf 0000000000-20-007746 40154
2020-08-14 8-K FORM 8-K 8.01,9.01 0001193125-20-220425 001-38624 201105659 34 33745
2020-08-14 424B5 424B5 0001193125-20-220408 333-236416 201105554 33 446884
2020-08-14 S-3 FORM S-3 0001193125-20-220395 333-246326 201105442 33 236590
2020-08-14 S-3 S-3 0001193125-20-220385 333-246322 201105355 33 231338
2020-08-14 10-Q 10-Q 0001564590-20-040174 001-38624 201101360 34 5926970 1
2020-08-11 D xslFormDX01/primary_doc.xml 06b 0001567619-20-014734 021-372997 201092577 33 12881
2020-07-31 8-K 8-K 1.01,2.03,3.02,9.01 0001193125-20-205401 001-38624 201063950 34 573256
2020-07-28 4/A PRIMARY DOCUMENT 0000891839-20-000214 13734
2020-07-27 4 PRIMARY DOCUMENT 0000891839-20-000213 11427
2020-07-16 SC 13G SCHEDULE 13G 0000899140-20-000338 005-90610 201032173 34 48945
2020-07-16 SC 13D/A SC 13D/A 0001019056-20-000418 005-90610 201031176 34 228116
2020-07-15 D xslFormDX01/primary_doc.xml 06b 0001567619-20-013306 021-371107 201029939 33 13624
2020-07-10 4 PRIMARY DOCUMENT 0000891839-20-000208 12651
2020-07-10 8-K FORM 8-K 1.01,3.02,9.01 0001193125-20-190745 001-38624 201021821 34 295467
2020-07-02 4 PRIMARY DOCUMENT 0000891839-20-000205 21358
2020-05-18 4 PRIMARY DOCUMENT 0000891839-20-000122 20829
2020-05-18 4 PRIMARY DOCUMENT 0000891839-20-000121 10255
2020-05-18 4 PRIMARY DOCUMENT 0000891839-20-000120 6769
2020-05-18 4 PRIMARY DOCUMENT 0000891839-20-000119 14838
2020-05-18 4 PRIMARY DOCUMENT 0000891839-20-000118 8201
2020-05-18 4 PRIMARY DOCUMENT 0000891839-20-000117 5313
2020-05-18 3 PRIMARY DOCUMENT 0000891839-20-000116 5798
2020-05-18 8-K 8-K 5.02,5.07 0001193125-20-144556 001-38624 20888095 34 24021
2020-05-14 10-Q 10-Q 0001564590-20-025279 001-38624 20875403 34 4403153 1
2020-04-08 DEF 14A DEF 14A 0001193125-20-101408 001-38624 20782273 34 645358
2020-04-01 4 PRIMARY DOCUMENT 0000891839-20-000086 20011
2020-03-30 4 PRIMARY DOCUMENT 0000891839-20-000084 14381
2020-03-27 8-K vaccinexform8k.htm 1.01,8.01,9.01 0001123292-20-000631 001-38624 20752974 34 768373
2020-03-27 424B5 424B5 0001193125-20-088935 333-236416 20752830 33 674200
2020-03-27 424B5 424B5 0001193125-20-088913 333-236416 20752717 33 698066
2020-03-26 4 PRIMARY DOCUMENT 0000891839-20-000083 14381
2020-03-23 4 PRIMARY DOCUMENT 0000891839-20-000079 14381
2020-03-17 4 PRIMARY DOCUMENT 0000891839-20-000078 15955
2020-03-12 UPLOAD filename1.pdf 0000000000-20-002211 45961
2020-03-11 EFFECT xslEFFECTX01/primary_doc.xml S-3,,2020-03-11 17:00:00 9999999995-20-000552 333-236417 20707065 33 1738
2020-03-11 EFFECT xslEFFECTX01/primary_doc.xml S-3,,2020-03-11 17:00:00 9999999995-20-000551 333-236416 20707064 33 1738
2020-03-11 4 PRIMARY DOCUMENT 0000891839-20-000075 14380
2020-03-09 CORRESP filename1.htm 0001193125-20-067342 5573
2020-03-09 CORRESP filename1.htm 0001193125-20-067341 5572
2020-03-09 10-K 10-K 0001564590-20-009251 001-38624 20696542 34 8308324 1
2020-02-26 8-K 8-K 5.02 0001193125-20-050123 001-38624 20656179 34 19439
2020-02-26 4 PRIMARY DOCUMENT 0000891839-20-000054 14481
2020-02-26 4 PRIMARY DOCUMENT 0000891839-20-000053 10466
2020-02-26 4 PRIMARY DOCUMENT 0000891839-20-000052 10791
2020-02-26 4 PRIMARY DOCUMENT 0000891839-20-000051 11785
2020-02-26 4 PRIMARY DOCUMENT 0000891839-20-000050 9263
2020-02-19 UPLOAD filename1.pdf 0000000000-20-001533 39898
2020-02-13 S-3 S-3 0001193125-20-035658 333-236417 20611303 33 488941
2020-02-13 S-3 FORM S-3 0001193125-20-035616 333-236416 20611046 33 425950
2020-02-10 3/A PRIMARY DOCUMENT 0000891839-20-000038 3919
2020-02-03 D xslFormDX01/primary_doc.xml 06b 0001567619-20-001927 021-359631 20568722 33 12917
2020-01-27 4 PRIMARY DOCUMENT 0000891839-20-000034 12590
2020-01-27 4 PRIMARY DOCUMENT 0000891839-20-000033 18022
2020-01-27 4 PRIMARY DOCUMENT 0000891839-20-000032 12860
2020-01-27 SC 13D/A SC 13D/A 0001019056-20-000029 005-90610 20548267 34 234238
2020-01-23 8-K 8-K 1.01,3.02,9.01 0001193125-20-013119 001-38624 20542500 34 310857
2020-01-15 4 PRIMARY DOCUMENT 0000891839-20-000030 12478
2020-01-15 4 PRIMARY DOCUMENT 0000891839-20-000029 15089
2020-01-06 4 PRIMARY DOCUMENT 0000891839-20-000018 13805
2020-01-06 4 PRIMARY DOCUMENT 0000891839-20-000017 16416
2020-01-06 4/A PRIMARY DOCUMENT 0000891839-20-000016 5794
2020-01-06 4/A PRIMARY DOCUMENT 0000891839-20-000015 5778
2019-11-12 10-Q 10-Q 0001564590-19-042537 001-38624 191206064 34 5969472 1
2019-10-08 EFFECT xslEFFECTX01/primary_doc.xml S-3,,2019-10-08 17:00:00 9999999995-19-002272 333-233607 191143653 33 1739
2019-10-04 CORRESP filename1.htm 0001193125-19-262780 6420
2019-10-04 4/A FORM 4/A SUBMISSION 0001209191-19-052508 001-38624 191137925 34 12482
2019-10-04 4/A FORM 4/A SUBMISSION 0001209191-19-052507 001-38624 191137887 34 15103
2019-10-04 4 FORM 4 SUBMISSION 0001209191-19-052506 11984
2019-10-04 4 FORM 4 SUBMISSION 0001209191-19-052505 14590
2019-10-02 4 FORM 4 SUBMISSION 0001209191-19-051418 001-38624 191130866 34 14932
2019-10-02 4 FORM 4 SUBMISSION 0001209191-19-051415 001-38624 191130783 34 12312
2019-09-27 S-3/A S-3/A 0001193125-19-257629 333-233607 191123849 33 446426
2019-09-27 CORRESP filename1.htm 0001193125-19-257641 14607
2019-09-18 UPLOAD filename1.pdf 0000000000-19-013686 43545
2019-09-03 S-3 FORM S-3 0001193125-19-236677 333-233607 191072693 33 465225
2019-08-15 SC 13G/A msdpartnersvaccinex13g.htm 0001123292-19-001061 005-90610 191031110 34 247938
2019-08-14 D xslFormDX01/primary_doc.xml 06b 0001567619-19-016996 021-346576 191026500 33 12920
2019-08-14 10-Q 10-Q 0001564590-19-031978 001-38624 191023014 34 5569352 1
2019-08-09 SC 13G msdpartnersvaccinex13g.htm 0001123292-19-001042 005-90610 191013722 34 281551
2019-07-31 SC 13D/A SC 13D/A 0001019056-19-000441 005-90610 19989235 34 227264
2019-07-31 4 PRIMARY DOCUMENT 0000891839-19-000143 14321
2019-07-31 4 PRIMARY DOCUMENT 0000891839-19-000142 12776
2019-07-31 8-K FORM 8-K 1.01,3.02,9.01 0001193125-19-207783 001-38624 19987361 34 302259
2019-07-29 4 PRIMARY DOCUMENT 0000891839-19-000134 14376

Latest XBRL company facts

One latest value per concept from companyfacts (221 concepts). Full history stays in the JSON.

TaxonomyTagLabelUnitValueStartEndFYFPFormFiledAccn
dei EntityCommonStockSharesOutstanding Entity Common Stock, Shares Outstanding shares 2.68M 2025-04-11 2024 FY 10-K 2025-04-15 0000950170-25-054318
dei EntityPublicFloat Entity Public Float USD 5.58M 2024-06-30 2024 FY 10-K 2025-04-15 0000950170-25-054318
us-gaap AccountsPayableCurrent Accounts Payable, Current USD 3.96M 2024-12-31 2024 FY 10-K 2025-04-15 0000950170-25-054318
us-gaap AccountsReceivableNetCurrent Accounts Receivable, after Allowance for Credit Loss, Current USD 838,000 2024-12-31 2024 FY 10-K 2025-04-15 0000950170-25-054318
us-gaap AccretionAmortizationOfDiscountsAndPremiumsInvestments Accretion (Amortization) of Discounts and Premiums, Investments USD 44,000 2019-01-01 2019-12-31 2020 FY 10-K 2021-03-31 0001564590-21-016874
us-gaap AccruedLiabilitiesCurrent Accrued Liabilities, Current USD 1.10M 2024-12-31 2024 FY 10-K 2025-04-15 0000950170-25-054318
us-gaap AccruedProfessionalFeesCurrent Accrued Professional Fees, Current USD 111,000 2024-12-31 2024 FY 10-K 2025-04-15 0000950170-25-054318
us-gaap AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment USD 7.18M 2024-12-31 2024 FY 10-K 2025-04-15 0000950170-25-054318
us-gaap AdditionalPaidInCapital Additional Paid in Capital USD 222.40M 2019-12-31 2019 FY 10-K 2020-03-09 0001564590-20-009251
us-gaap AdditionalPaidInCapitalCommonStock Additional Paid in Capital, Common Stock USD 354.42M 2024-12-31 2024 FY 10-K 2025-04-15 0000950170-25-054318
us-gaap AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue APIC, Share-based Payment Arrangement, Increase for Cost Recognition USD 341,000 2024-01-01 2024-12-31 2024 FY 10-K 2025-04-15 0000950170-25-054318
us-gaap AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts Adjustments to Additional Paid in Capital, Stock Issued, Issuance Costs USD 985,000 2021-01-01 2021-12-31 2022 FY 10-K 2023-03-31 0000950170-23-011354
us-gaap AdjustmentsToAdditionalPaidInCapitalWarrantIssued Adjustments to Additional Paid in Capital, Warrant Issued USD 1.99M 2024-07-01 2024-09-30 2024 Q3 10-Q 2024-11-14 0000950170-24-127139
us-gaap AllocatedShareBasedCompensationExpense Share-based Payment Arrangement, Expense USD 341,000 2024-01-01 2024-12-31 2024 FY 10-K 2025-04-15 0000950170-25-054318
us-gaap AmortizationOfDebtDiscountPremium Amortization of Debt Discount (Premium) USD 308,000 2018-01-01 2018-12-31 2019 FY 10-K 2020-03-09 0001564590-20-009251
us-gaap AssetImpairmentCharges Asset Impairment Charges USD 0 2024-01-01 2024-12-31 2024 FY 10-K 2025-04-15 0000950170-25-054318
us-gaap Assets Assets USD 2.60M 2024-12-31 2024 FY 10-K 2025-04-15 0000950170-25-054318
us-gaap AssetsCurrent Assets, Current USD 2.53M 2024-12-31 2024 FY 10-K 2025-04-15 0000950170-25-054318
us-gaap AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax Debt Securities, Available-for-sale, Accumulated Gross Unrealized Gain, before Tax USD 0 2018-12-31 2019 FY 10-K 2020-03-09 0001564590-20-009251
us-gaap AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax Debt Securities, Available-for-sale, Accumulated Gross Unrealized Loss, before Tax USD 0 2018-12-31 2019 FY 10-K 2020-03-09 0001564590-20-009251
us-gaap AvailableForSaleDebtSecuritiesAmortizedCostBasis Debt Securities, Available-for-sale, Amortized Cost USD 14.11M 2018-12-31 2019 FY 10-K 2020-03-09 0001564590-20-009251
us-gaap AvailableForSaleSecurities Available-for-sale Securities USD 16.12M 2018-09-30 2018 Q3 10-Q 2018-11-13 0001564590-18-029125
us-gaap AvailableForSaleSecuritiesAmortizedCost Available-for-sale Securities, Amortized Cost Basis USD 16.12M 2018-09-30 2018 Q3 10-Q 2018-11-13 0001564590-18-029125
us-gaap AvailableForSaleSecuritiesDebtSecurities Debt Securities, Available-for-sale USD 14.11M 2018-12-31 2019 FY 10-K 2020-03-09 0001564590-20-009251
us-gaap CapitalExpendituresIncurredButNotYetPaid Capital Expenditures Incurred but Not yet Paid USD 7,000 2021-01-01 2021-09-30 2022 Q3 10-Q 2022-11-14 0001564590-22-037499
us-gaap Cash Cash USD 1.30M 2018-06-30 2018 Q2 10-Q 2018-08-14 0001564590-18-021566
us-gaap CashAndCashEquivalentsAtCarryingValue Cash and Cash Equivalents, at Carrying Value USD 1.11M 2024-12-31 2024 FY 10-K 2025-04-15 0000950170-25-054318
us-gaap CashAndCashEquivalentsPeriodIncreaseDecrease Cash and Cash Equivalents, Period Increase (Decrease) USD -339,000 2019-01-01 2019-06-30 2019 Q2 10-Q 2019-08-14 0001564590-19-031978
us-gaap CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations USD 1.11M 2024-12-31 2024 FY 10-K 2025-04-15 0000950170-25-054318
us-gaap CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect USD -428,000 2024-01-01 2024-12-31 2024 FY 10-K 2025-04-15 0000950170-25-054318
us-gaap CommonStockCapitalSharesReservedForFutureIssuance Common Stock, Capital Shares Reserved for Future Issuance shares 3.01M 2024-12-31 2024 FY 10-K 2025-04-15 0000950170-25-054318
us-gaap CommonStockParOrStatedValuePerShare Common Stock, Par or Stated Value Per Share USD/shares 0 2024-12-31 2024 FY 10-K 2025-04-15 0000950170-25-054318
us-gaap CommonStockSharesAuthorized Common Stock, Shares Authorized shares 100.00M 2024-12-31 2024 FY 10-K 2025-04-15 0000950170-25-054318
us-gaap CommonStockSharesIssued Common Stock, Shares, Issued shares 2.68M 2024-12-31 2024 FY 10-K 2025-04-15 0000950170-25-054318
us-gaap CommonStockSharesOutstanding Common Stock, Shares, Outstanding shares 2.68M 2024-12-31 2024 FY 10-K 2025-04-15 0000950170-25-054318
us-gaap CommonStockValue Common Stock, Value, Issued USD 1,000 2024-12-31 2024 FY 10-K 2025-04-15 0000950170-25-054318
us-gaap ComprehensiveIncomeNetOfTax Comprehensive Income (Loss), Net of Tax, Attributable to Parent USD -18.63M 2024-01-01 2024-12-31 2024 FY 10-K 2025-04-15 0000950170-25-054318
us-gaap ContractWithCustomerLiabilityCurrent Contract with Customer, Liability, Current USD 0 2024-12-31 2024 FY 10-K 2025-04-15 0000950170-25-054318
us-gaap ConvertibleDebt Convertible Debt USD 0 2021-08-03 2022 FY 10-K 2023-03-31 0000950170-23-011354
us-gaap ConvertibleLongTermNotesPayable Convertible Notes Payable, Noncurrent USD 1.28M 2018-06-30 2018 Q2 10-Q 2018-08-14 0001564590-18-021566
us-gaap ConvertibleNotesPayableCurrent Convertible Notes Payable, Current USD 1.28M 2018-06-30 2018 Q2 10-Q 2018-08-14 0001564590-18-021566
us-gaap CostOfRevenue Cost of Revenue USD 2,000 2020-01-01 2020-12-31 2021 FY 10-K 2022-03-31 0001564590-22-012778
us-gaap CostsAndExpenses Costs and Expenses USD 19.34M 2024-01-01 2024-12-31 2024 FY 10-K 2025-04-15 0000950170-25-054318
us-gaap DebtInstrumentBasisSpreadOnVariableRate1 Debt Instrument, Basis Spread on Variable Rate pure 0.02 2017-10-01 2017-10-31 2019 FY 10-K 2020-03-09 0001564590-20-009251
us-gaap DebtInstrumentCarryingAmount Long-term Debt, Gross USD 6.00M 2017-10-31 2019 FY 10-K 2020-03-09 0001564590-20-009251
us-gaap DebtInstrumentFaceAmount Debt Instrument, Face Amount USD 10.00M 2017-01-31 2019 FY 10-K 2020-03-09 0001564590-20-009251
us-gaap DebtInstrumentPeriodicPaymentPrincipal Debt Instrument, Periodic Payment, Principal USD 6.00M 2017-01-01 2017-01-31 2019 FY 10-K 2020-03-09 0001564590-20-009251
us-gaap DebtInstrumentUnamortizedDiscount Debt Instrument, Unamortized Discount USD 223,000 2018-06-30 2018 Q2 10-Q 2018-08-14 0001564590-18-021566
us-gaap DeferredOfferingCosts Deferred Offering Costs USD 0 2021-12-31 2021 FY 10-K 2022-03-31 0001564590-22-012778
us-gaap DeferredRevenueCurrent Deferred Revenue, Current USD 42,000 2018-09-30 2018 Q3 10-Q 2018-11-13 0001564590-18-029125
us-gaap DeferredTaxAssetsDeferredIncome Deferred Tax Assets, Deferred Income USD 78,000 2017-12-31 2018 FY 10-K 2019-03-13 0001564590-19-007458
us-gaap DeferredTaxAssetsDerivativeInstruments Deferred Tax Assets, Derivative Instruments USD 96,000 2017-12-31 2018 FY 10-K 2019-03-13 0001564590-19-007458
us-gaap DeferredTaxAssetsGross Deferred Tax Assets, Gross USD 115.49M 2024-12-31 2024 FY 10-K 2025-04-15 0000950170-25-054318
us-gaap DeferredTaxAssetsInProcessResearchAndDevelopment Deferred Tax Assets, in Process Research and Development USD 24.63M 2024-12-31 2024 FY 10-K 2025-04-15 0000950170-25-054318
us-gaap DeferredTaxAssetsLiabilitiesNet Deferred Tax Assets, Net USD 0 2024-12-31 2024 FY 10-K 2025-04-15 0000950170-25-054318
us-gaap DeferredTaxAssetsNet Deferred Tax Assets, Net of Valuation Allowance USD 696,000 2017-12-31 2018 FY 10-K 2019-03-13 0001564590-19-007458
us-gaap DeferredTaxAssetsOperatingLossCarryforwards Deferred Tax Assets, Operating Loss Carryforwards USD 82.34M 2024-12-31 2024 FY 10-K 2025-04-15 0000950170-25-054318
us-gaap DeferredTaxAssetsOther Deferred Tax Assets, Other USD 633,000 2024-12-31 2024 FY 10-K 2025-04-15 0000950170-25-054318
us-gaap DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsReserves Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals, Reserves USD 76,000 2024-12-31 2024 FY 10-K 2025-04-15 0000950170-25-054318
us-gaap DeferredTaxAssetsValuationAllowance Deferred Tax Assets, Valuation Allowance USD 115.49M 2024-12-31 2024 FY 10-K 2025-04-15 0000950170-25-054318
us-gaap DeferredTaxLiabilitiesDeferredExpenseDeferredFinancingCosts Deferred Tax Liabilities, Deferred Expense, Debt Issuance Costs USD 696,000 2017-12-31 2018 FY 10-K 2019-03-13 0001564590-19-007458
us-gaap DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent Defined Contribution Plan, Maximum Annual Contributions Per Employee, Percent pure 1 2024-01-01 2024-12-31 2024 FY 10-K 2025-04-15 0000950170-25-054318
us-gaap Depreciation Depreciation USD 94,000 2024-01-01 2024-12-31 2024 FY 10-K 2025-04-15 0000950170-25-054318
us-gaap DepreciationDepletionAndAmortization Depreciation, Depletion and Amortization USD 249,000 2019-01-01 2019-12-31 2019 FY 10-K 2020-03-09 0001564590-20-009251
us-gaap DerivativeAssets Derivative Asset USD 14 2024-09-30 2024 Q3 10-Q 2024-11-14 0000950170-24-127139
us-gaap DerivativeAssetsCurrent Derivative Asset, Current USD 0 2024-12-31 2024 FY 10-K 2025-04-15 0000950170-25-054318
us-gaap DerivativeGainLossOnDerivativeNet Derivative, Gain (Loss) on Derivative, Net USD 369,000 2018-01-01 2018-12-31 2019 FY 10-K 2020-03-09 0001564590-20-009251
us-gaap DerivativeLiabilities Derivative Liability USD 369,000 2017-12-31 2018 FY 10-K 2019-03-13 0001564590-19-007458
us-gaap DerivativeLiabilitiesCurrent Derivative Liability, Current USD 0 2024-12-31 2024 FY 10-K 2025-04-15 0000950170-25-054318
us-gaap DerivativeLiabilitiesNoncurrent Derivative Liability, Noncurrent USD 369,000 2017-12-31 2018 FY 10-K 2019-03-13 0001564590-19-007458
us-gaap DividendsPayableCurrentAndNoncurrent Dividends Payable USD 0 2018-12-31 2018 FY 10-K 2019-03-13 0001564590-19-007458
us-gaap DividendsPreferredStock Dividends, Preferred Stock USD 0 2018-01-01 2018-12-31 2018 FY 10-K 2019-03-13 0001564590-19-007458
us-gaap EarningsPerShareBasic Earnings Per Share, Basic USD/shares -8.88 2024-01-01 2024-12-31 2024 FY 10-K 2025-04-15 0000950170-25-054318
us-gaap EarningsPerShareBasicAndDiluted Earnings Per Share, Basic and Diluted USD/shares -0.12 2022-01-01 2022-03-31 2022 Q1 10-Q 2022-05-16 0001564590-22-020252
us-gaap EarningsPerShareDiluted Earnings Per Share, Diluted USD/shares -8.88 2024-01-01 2024-12-31 2024 FY 10-K 2025-04-15 0000950170-25-054318
us-gaap EffectiveIncomeTaxRateContinuingOperations Effective Income Tax Rate Reconciliation, Percent pure 0 2024-01-01 2024-12-31 2024 FY 10-K 2025-04-15 0000950170-25-054318
us-gaap EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent pure 0.21 2024-01-01 2024-12-31 2024 FY 10-K 2025-04-15 0000950170-25-054318
us-gaap EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Percent pure -0.312 2024-01-01 2024-12-31 2024 FY 10-K 2025-04-15 0000950170-25-054318
us-gaap EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate Effective Income Tax Rate Reconciliation, Change in Enacted Tax Rate, Percent pure -1.103 2017-01-01 2017-12-31 2018 FY 10-K 2019-03-13 0001564590-19-007458
us-gaap EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther Effective Income Tax Rate Reconciliation, Nondeductible Expense, Other, Percent pure 0.004 2024-01-01 2024-12-31 2024 FY 10-K 2025-04-15 0000950170-25-054318
us-gaap EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Percent pure 0.053 2024-01-01 2024-12-31 2024 FY 10-K 2025-04-15 0000950170-25-054318
us-gaap EffectiveIncomeTaxRateReconciliationTaxCreditsResearch Effective Income Tax Rate Reconciliation, Tax Credit, Research, Percent pure -0.045 2024-01-01 2024-12-31 2024 FY 10-K 2025-04-15 0000950170-25-054318
us-gaap EmbeddedDerivativeFairValueOfEmbeddedDerivativeLiability Embedded Derivative, Fair Value of Embedded Derivative Liability USD 0 2020-12-31 2021 FY 10-K 2022-03-31 0001564590-22-012778
us-gaap EmployeeRelatedLiabilitiesCurrent Employee-related Liabilities, Current USD 223,000 2024-12-31 2024 FY 10-K 2025-04-15 0000950170-25-054318
us-gaap EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount USD 242,067 2024-12-31 2024 FY 10-K 2025-04-15 0000950170-25-054318
us-gaap FairValueAdjustmentOfWarrants Fair Value Adjustment of Warrants USD -1.29M 2024-01-01 2024-12-31 2024 FY 10-K 2025-04-15 0000950170-25-054318
us-gaap FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationIssues Fair Value, Net Derivative Asset (Liability) Measured on Recurring Basis, Unobservable Inputs Reconciliation, Issues USD 3.42M 2017-01-01 2017-12-31 2018 FY 10-K 2019-03-13 0001564590-19-007458
us-gaap FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationPeriodIncreaseDecrease Fair Value, Net Derivative Asset (Liability) Measured on Recurring Basis, Unobservable Inputs Reconciliation, Period Increase (Decrease) USD -369,000 2018-01-01 2018-12-31 2018 FY 10-K 2019-03-13 0001564590-19-007458
us-gaap GainsLossesOnExtinguishmentOfDebt Gain (Loss) on Extinguishment of Debt USD -2.38M 2018-01-01 2018-12-31 2019 FY 10-K 2020-03-09 0001564590-20-009251
us-gaap GeneralAndAdministrativeExpense General and Administrative Expense USD 6.79M 2024-01-01 2024-12-31 2024 FY 10-K 2025-04-15 0000950170-25-054318
us-gaap IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest USD -18.63M 2024-01-01 2024-12-31 2024 FY 10-K 2025-04-15 0000950170-25-054318
us-gaap IncomeTaxExaminationInterestAccrued Income Tax Examination, Interest Accrued USD 0 2024-12-31 2024 FY 10-K 2025-04-15 0000950170-25-054318
us-gaap IncomeTaxExaminationPenaltiesAccrued Income Tax Examination, Penalties Accrued USD 0 2023-12-31 2024 FY 10-K 2025-04-15 0000950170-25-054318
us-gaap IncomeTaxExpenseBenefit Income Tax Expense (Benefit) USD 0 2024-01-01 2024-12-31 2024 FY 10-K 2025-04-15 0000950170-25-054318
us-gaap IncreaseDecreaseInAccountsPayable Increase (Decrease) in Accounts Payable USD 1.91M 2024-01-01 2024-12-31 2024 FY 10-K 2025-04-15 0000950170-25-054318
us-gaap IncreaseDecreaseInAccountsReceivable Increase (Decrease) in Accounts Receivable USD -123,000 2024-01-01 2024-12-31 2024 FY 10-K 2025-04-15 0000950170-25-054318
us-gaap IncreaseDecreaseInAccruedLiabilities Increase (Decrease) in Accrued Liabilities USD -138,000 2024-01-01 2024-12-31 2024 FY 10-K 2025-04-15 0000950170-25-054318
us-gaap IncreaseDecreaseInContractWithCustomerLiability Increase (Decrease) in Contract with Customer, Liability USD -298,000 2018-01-01 2018-12-31 2019 FY 10-K 2020-03-09 0001564590-20-009251
us-gaap IncreaseDecreaseInDeferredRevenue Increase (Decrease) in Deferred Revenue USD -63,000 2024-01-01 2024-12-31 2024 FY 10-K 2025-04-15 0000950170-25-054318
us-gaap IncreaseDecreaseInDerivativeLiabilities Increase (Decrease) in Derivative Liabilities USD -65,000 2020-01-01 2020-12-31 2021 FY 10-K 2022-03-31 0001564590-22-012778
us-gaap IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets Increase (Decrease) in Prepaid Expense and Other Assets USD -267,000 2024-01-01 2024-12-31 2024 FY 10-K 2025-04-15 0000950170-25-054318
us-gaap InterestExpense Interest Expense USD 2,000 2024-01-01 2024-12-31 2024 FY 10-K 2025-04-15 0000950170-25-054318
us-gaap InterestExpenseDebt Interest Expense, Debt USD 458,000 2021-01-01 2021-12-31 2022 FY 10-K 2023-03-31 0000950170-23-011354
us-gaap InterestPaidNet Interest Paid, Excluding Capitalized Interest, Operating Activities USD 275,000 2018-01-01 2018-12-31 2019 FY 10-K 2020-03-09 0001564590-20-009251
us-gaap InterestPayableCurrent Interest Payable, Current USD 192,000 2017-12-31 2018 FY 10-K 2019-03-13 0001564590-19-007458
us-gaap InterestPayableCurrentAndNoncurrent Interest Payable USD 390,000 2018-06-30 2018 Q2 10-Q 2018-08-14 0001564590-18-021566
us-gaap LesseeOperatingLeaseDiscountRate Lessee, Operating Lease, Discount Rate pure 0.07 2024-09-30 2024 Q3 10-Q 2024-11-14 0000950170-24-127139
us-gaap LesseeOperatingLeaseLiabilityUndiscountedExcessAmount Lessee, Operating Lease, Liability, Undiscounted Excess Amount USD 4,718 2023-12-31 2024 FY 10-K 2025-04-15 0000950170-25-054318
us-gaap Liabilities Liabilities USD 5.08M 2024-12-31 2024 FY 10-K 2025-04-15 0000950170-25-054318
us-gaap LiabilitiesAndStockholdersEquity Liabilities and Equity USD 2.60M 2024-12-31 2024 FY 10-K 2025-04-15 0000950170-25-054318
us-gaap LiabilitiesCurrent Liabilities, Current USD 5.08M 2024-12-31 2024 FY 10-K 2025-04-15 0000950170-25-054318
us-gaap LongTermDebtCurrent Long-term Debt, Current Maturities USD 25,000 2024-12-31 2024 FY 10-K 2025-04-15 0000950170-25-054318
us-gaap LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo Long-Term Debt, Maturity, Year Two USD 1.89M 2018-06-30 2018 Q2 10-Q 2018-08-14 0001564590-18-021566
us-gaap LongTermDebtNoncurrent Long-term Debt, Excluding Current Maturities USD 0 2024-12-31 2024 FY 10-K 2025-04-15 0000950170-25-054318
us-gaap MarketableSecuritiesCurrent Marketable Securities, Current USD 0 2019-12-31 2019 FY 10-K 2020-03-09 0001564590-20-009251
us-gaap MinorityInterest Stockholders' Equity Attributable to Noncontrolling Interest USD 23.96M 2020-12-31 2021 FY 10-K 2022-03-31 0001564590-22-012778
us-gaap NetCashProvidedByUsedInFinancingActivities Net Cash Provided by (Used in) Financing Activities USD 15.78M 2024-01-01 2024-12-31 2024 FY 10-K 2025-04-15 0000950170-25-054318
us-gaap NetCashProvidedByUsedInInvestingActivities Net Cash Provided by (Used in) Investing Activities USD -22,000 2024-01-01 2024-12-31 2024 FY 10-K 2025-04-15 0000950170-25-054318
us-gaap NetCashProvidedByUsedInOperatingActivities Net Cash Provided by (Used in) Operating Activities USD -16.19M 2024-01-01 2024-12-31 2024 FY 10-K 2025-04-15 0000950170-25-054318
us-gaap NetIncomeLoss Net Income (Loss) Attributable to Parent USD -18.63M 2024-01-01 2024-12-31 2024 FY 10-K 2025-04-15 0000950170-25-054318
us-gaap NetIncomeLossAttributableToNoncontrollingInterest Net Income (Loss) Attributable to Noncontrolling Interest USD 0 2022-01-01 2022-09-30 2022 Q3 10-Q 2022-11-14 0001564590-22-037499
us-gaap NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1 Noncash or Part Noncash Acquisition, Fixed Assets Acquired USD 19,000 2021-01-01 2021-12-31 2022 FY 10-K 2023-03-31 0000950170-23-011354
us-gaap NoncontrollingInterestIncreaseFromSaleOfParentEquityInterest Noncontrolling Interest, Increase from Sale of Parent Equity Interest USD 12.00M 2018-01-01 2018-12-31 2019 FY 10-K 2020-03-09 0001564590-20-009251
us-gaap NotesPayableRelatedPartiesClassifiedCurrent Notes Payable, Related Parties, Current USD 1.28M 2018-06-30 2018 Q2 10-Q 2018-08-14 0001564590-18-021566
us-gaap NotesPayableRelatedPartiesNoncurrent Notes Payable, Related Parties, Noncurrent USD 2.81M 2017-12-31 2018 FY 10-K 2019-03-13 0001564590-19-007458
us-gaap NumberOfOperatingSegments Number of Operating Segments Segment 1 2023-01-01 2023-12-31 2023 FY 10-K/A 2024-04-25 0000950170-24-048163
us-gaap OperatingIncomeLoss Operating Income (Loss) USD -18.73M 2024-01-01 2024-12-31 2024 FY 10-K 2025-04-15 0000950170-25-054318
us-gaap OperatingLeaseExpense Operating Lease, Expense USD 181,000 2024-01-01 2024-12-31 2024 FY 10-K 2025-04-15 0000950170-25-054318
us-gaap OperatingLeaseLiability Operating Lease, Liability USD 145,764 2023-12-31 2024 FY 10-K 2025-04-15 0000950170-25-054318
us-gaap OperatingLeaseLiabilityCurrent Operating Lease, Liability, Current USD 0 2024-12-31 2024 FY 10-K 2025-04-15 0000950170-25-054318
us-gaap OperatingLeaseLiabilityNoncurrent Operating Lease, Liability, Noncurrent USD 146,000 2022-12-31 2023 FY 10-K/A 2024-04-25 0000950170-24-048163
us-gaap OperatingLeasePayments Operating Lease, Payments USD 181,000 2023-01-01 2023-12-31 2024 FY 10-K 2025-04-15 0000950170-25-054318
us-gaap OperatingLeaseRightOfUseAsset Operating Lease, Right-of-Use Asset USD 0 2024-12-31 2024 FY 10-K 2025-04-15 0000950170-25-054318
us-gaap OperatingLeasesFutureMinimumPaymentsDue Operating Leases, Future Minimum Payments Due USD 150,480 2024-12-31 2024 FY 10-K 2025-04-15 0000950170-25-054318
us-gaap OperatingLeasesFutureMinimumPaymentsDueCurrent Operating Leases, Future Minimum Payments Due, Next Twelve Months USD 174,132 2020-12-31 2020 FY 10-K 2021-03-31 0001564590-21-016874
us-gaap OperatingLeasesFutureMinimumPaymentsDueInFiveYears Operating Leases, Future Minimum Payments, Due in Five Years USD 0 2020-06-30 2020 Q2 10-Q 2020-08-14 0001564590-20-040174
us-gaap OperatingLeasesFutureMinimumPaymentsDueInFourYears Operating Leases, Future Minimum Payments, Due in Four Years USD 0 2020-06-30 2020 Q2 10-Q 2020-08-14 0001564590-20-040174
us-gaap OperatingLeasesFutureMinimumPaymentsDueInThreeYears Operating Leases, Future Minimum Payments, Due in Three Years USD 150.48M 2022-09-30 2022 Q3 10-Q 2022-11-14 0001564590-22-037499
us-gaap OperatingLeasesFutureMinimumPaymentsDueInTwoYears Operating Leases, Future Minimum Payments, Due in Two Years USD 331,060 2022-12-31 2022 FY 10-K 2023-03-31 0000950170-23-011354
us-gaap OperatingLeasesFutureMinimumPaymentsRemainderOfFiscalYear Operating Leases, Future Minimum Payments, Remainder of Fiscal Year USD 44.61M 2022-09-30 2022 Q3 10-Q 2022-11-14 0001564590-22-037499
us-gaap OperatingLeasesRentExpenseNet Operating Leases, Rent Expense, Net USD 45,144 2023-01-01 2023-03-31 2023 Q1 10-Q 2023-05-15 0000950170-23-022252
us-gaap OtherAccruedLiabilitiesCurrent Other Accrued Liabilities, Current USD 77,000 2024-12-31 2024 FY 10-K 2025-04-15 0000950170-25-054318
us-gaap OtherNonoperatingIncomeExpense Other Nonoperating Income (Expense) USD 41,000 2024-01-01 2024-12-31 2024 FY 10-K 2025-04-15 0000950170-25-054318
us-gaap PaymentsOfDebtExtinguishmentCosts Payment for Debt Extinguishment or Debt Prepayment Cost USD 0 2021-08-03 2022 FY 10-K 2023-03-31 0000950170-23-011354
us-gaap PaymentsOfDebtIssuanceCosts Payments of Debt Issuance Costs USD 50,000 2020-01-01 2020-12-31 2021 FY 10-K 2022-03-31 0001564590-22-012778
us-gaap PaymentsOfStockIssuanceCosts Payments of Stock Issuance Costs USD 985,000 2021-01-01 2021-12-31 2022 FY 10-K 2023-03-31 0000950170-23-011354
us-gaap PaymentsToAcquireMarketableSecurities Payments to Acquire Marketable Securities USD 20.76M 2018-01-01 2018-12-31 2019 FY 10-K 2020-03-09 0001564590-20-009251
us-gaap PaymentsToAcquirePropertyPlantAndEquipment Payments to Acquire Property, Plant, and Equipment USD 22,000 2024-01-01 2024-12-31 2024 FY 10-K 2025-04-15 0000950170-25-054318
us-gaap PreferredStockDividendsIncomeStatementImpact Preferred Stock Dividends, Income Statement Impact USD 3.21M 2017-01-01 2017-12-31 2018 FY 10-K 2019-03-13 0001564590-19-007458
us-gaap PreferredStockLiquidationPreferenceValue Preferred Stock, Liquidation Preference, Value USD 1.75B 2024-12-31 2024 FY 10-K 2025-04-15 0000950170-25-054318
us-gaap PreferredStockParOrStatedValuePerShare Preferred Stock, Par or Stated Value Per Share USD/shares 0.001 2024-12-31 2024 FY 10-K 2025-04-15 0000950170-25-054318
us-gaap PreferredStockSharesAuthorized Preferred Stock, Shares Authorized shares 10.00M 2024-12-31 2024 FY 10-K 2025-04-15 0000950170-25-054318
us-gaap PreferredStockSharesIssued Preferred Stock, Shares Issued shares 10 2024-12-31 2024 FY 10-K 2025-04-15 0000950170-25-054318
us-gaap PreferredStockSharesOutstanding Preferred Stock, Shares Outstanding shares 10 2024-12-31 2024 FY 10-K 2025-04-15 0000950170-25-054318
us-gaap PreferredStockValue Preferred Stock, Value, Issued USD 1.67M 2024-12-31 2024 FY 10-K 2025-04-15 0000950170-25-054318
us-gaap PrepaidExpenseAndOtherAssetsCurrent Prepaid Expense and Other Assets, Current USD 586,000 2024-12-31 2024 FY 10-K 2025-04-15 0000950170-25-054318
us-gaap ProceedsFromContributedCapital Proceeds from Contributed Capital USD 11.50M 2020-03-27 2024 FY 10-K 2025-04-15 0000950170-25-054318
us-gaap ProceedsFromIssuanceInitialPublicOffering Proceeds from Issuance Initial Public Offering USD 37.13M 2018-01-01 2018-12-31 2019 FY 10-K 2020-03-09 0001564590-20-009251
us-gaap ProceedsFromIssuanceOfCommonStock Proceeds from Issuance of Common Stock USD 1.27M 2023-01-01 2023-09-30 2024 Q3 10-Q 2024-11-14 0000950170-24-127139
us-gaap ProceedsFromIssuanceOfLongTermDebt Proceeds from Issuance of Long-term Debt USD 1.13M 2020-01-01 2020-12-31 2021 FY 10-K 2022-03-31 0001564590-22-012778
us-gaap ProceedsFromIssuanceOfPreferredStockPreferenceStockAndWarrants Proceeds from Issuance of Preferred Stock, Preference Stock, and Warrants USD 1.70M 2024-01-01 2024-12-31 2024 FY 10-K 2025-04-15 0000950170-25-054318
us-gaap ProceedsFromIssuanceOfPrivatePlacement Proceeds from Issuance of Private Placement USD 7.30M 2023-01-01 2023-12-31 2024 FY 10-K 2025-04-15 0000950170-25-054318
us-gaap ProceedsFromRelatedPartyDebt Proceeds from Related Party Debt USD 9.98M 2017-01-01 2017-12-31 2018 FY 10-K 2019-03-13 0001564590-19-007458
us-gaap ProceedsFromSaleAndMaturityOfMarketableSecurities Proceeds from Sale and Maturity of Marketable Securities USD 14.15M 2019-01-01 2019-12-31 2020 FY 10-K 2021-03-31 0001564590-21-016874
us-gaap ProceedsFromStockOptionsExercised Proceeds from Stock Options Exercised USD 19,000 2020-01-01 2020-12-31 2021 FY 10-K 2022-03-31 0001564590-22-012778
us-gaap ProceedsFromWarrantExercises Proceeds from Warrant Exercises USD 5.92M 2024-01-01 2024-12-31 2024 FY 10-K 2025-04-15 0000950170-25-054318
us-gaap ProfitLoss Net Income (Loss), Including Portion Attributable to Noncontrolling Interest USD -18.63M 2024-01-01 2024-12-31 2024 FY 10-K 2025-04-15 0000950170-25-054318
us-gaap PropertyPlantAndEquipmentGross Property, Plant and Equipment, Gross USD 7.25M 2024-12-31 2024 FY 10-K 2025-04-15 0000950170-25-054318
us-gaap PropertyPlantAndEquipmentNet Property, Plant and Equipment, Net USD 65,000 2024-12-31 2024 FY 10-K 2025-04-15 0000950170-25-054318
us-gaap RepaymentsOfLongTermDebt Repayments of Long-term Debt USD 76,000 2024-01-01 2024-12-31 2024 FY 10-K 2025-04-15 0000950170-25-054318
us-gaap RepaymentsOfRelatedPartyDebt Repayments of Related Party Debt USD 5.50M 2018-01-01 2018-12-31 2019 FY 10-K 2020-03-09 0001564590-20-009251
us-gaap ResearchAndDevelopmentExpense Research and Development Expense USD 12.54M 2024-01-01 2024-12-31 2024 FY 10-K 2025-04-15 0000950170-25-054318
us-gaap RetainedEarningsAccumulatedDeficit Retained Earnings (Accumulated Deficit) USD -358.56M 2024-12-31 2024 FY 10-K 2025-04-15 0000950170-25-054318
us-gaap RevenueFromContractWithCustomerExcludingAssessedTax Revenue from Contract with Customer, Excluding Assessed Tax USD 601,000 2024-01-01 2024-12-31 2024 FY 10-K 2025-04-15 0000950170-25-054318
us-gaap RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability Right-of-Use Asset Obtained in Exchange for Operating Lease Liability USD 300,000 2021-01-01 2022 FY 10-K 2023-03-31 0000950170-23-011354
us-gaap SaleOfStockConsiderationReceivedOnTransaction Sale of Stock, Consideration Received on Transaction USD 37.60M 2020-01-01 2020-12-31 2021 FY 10-K 2022-03-31 0001564590-22-012778
us-gaap ShareBasedCompensation Share-based Payment Arrangement, Noncash Expense USD 341,000 2024-01-01 2024-12-31 2024 FY 10-K 2025-04-15 0000950170-25-054318
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate pure 0 2024-01-01 2024-12-31 2024 FY 10-K 2025-04-15 0000950170-25-054318
us-gaap SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1 Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value USD 0 2024-09-30 2024 Q3 10-Q 2024-11-14 0000950170-24-127139
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number shares 14,534 2024-12-31 2024 FY 10-K 2025-04-15 0000950170-25-054318
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price USD/shares 327.7 2024-12-31 2024 FY 10-K 2025-04-15 0000950170-25-054318
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value USD 3,000 2020-01-01 2020-12-31 2021 FY 10-K 2022-03-31 0001564590-22-012778
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod Share-based Compensation Arrangement by Share-based Payment Award, Options, Expirations in Period shares 24 2024-01-01 2024-12-31 2024 FY 10-K 2025-04-15 0000950170-25-054318
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period shares 15,784 2024-01-01 2024-12-31 2024 FY 10-K 2025-04-15 0000950170-25-054318
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross shares 73,906 2024-01-01 2024-12-31 2024 FY 10-K 2025-04-15 0000950170-25-054318
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value USD/shares 3.79 2024-01-01 2024-12-31 2024 FY 10-K 2025-04-15 0000950170-25-054318
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value USD 4,000 2022-12-31 2024 FY 10-K 2025-04-15 0000950170-25-054318
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number shares 72,421 2024-12-31 2024 FY 10-K 2025-04-15 0000950170-25-054318
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price USD/shares 79.21 2024-12-31 2024 FY 10-K 2025-04-15 0000950170-25-054318
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Aggregate Intrinsic Value USD 3,000 2020-03-31 2020 Q1 10-Q 2020-05-14 0001564590-20-025279
us-gaap SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1 Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested in Period, Fair Value USD 453,057 2024-01-01 2024-12-31 2024 FY 10-K 2025-04-15 0000950170-25-054318
us-gaap ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price USD/shares 5.11 2020-01-01 2020-12-31 2021 FY 10-K 2022-03-31 0001564590-22-012778
us-gaap ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice Share-based Compensation Arrangements by Share-based Payment Award, Options, Expirations in Period, Weighted Average Exercise Price USD/shares 3,129 2024-01-01 2024-12-31 2024 FY 10-K 2025-04-15 0000950170-25-054318
us-gaap ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice Share-based Compensation Arrangements by Share-based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price USD/shares 76.93 2024-01-01 2024-12-31 2024 FY 10-K 2025-04-15 0000950170-25-054318
us-gaap ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price USD/shares 5.75 2024-01-01 2024-12-31 2024 FY 10-K 2025-04-15 0000950170-25-054318
us-gaap SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1 Share-based Payment Arrangement, Option, Exercise Price Range, Exercisable, Weighted Average Exercise Price USD/shares 9.49 2018-09-30 2018 Q3 10-Q 2018-11-13 0001564590-18-029125
us-gaap SharesOutstanding Shares, Outstanding shares 4.86M 2023-09-30 2023 Q3 10-Q 2023-11-13 0000950170-23-062454
us-gaap StockholdersEquity Stockholders' Equity Attributable to Parent USD 7.41M 2021-12-31 2021 FY 10-K 2022-03-31 0001564590-22-012778
us-gaap StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest USD -2.49M 2024-12-31 2024 FY 10-K 2025-04-15 0000950170-25-054318
us-gaap StockholdersEquityNoteStockSplitConversionRatio1 Stockholders' Equity Note, Stock Split, Conversion Ratio pure 0.14 2024-02-19 2024 FY 10-K 2025-04-15 0000950170-25-054318
us-gaap StockIssuedDuringPeriodSharesStockOptionsExercised Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period shares 3,783 2020-01-01 2020-12-31 2021 FY 10-K 2022-03-31 0001564590-22-012778
us-gaap StockIssuedDuringPeriodValueConversionOfConvertibleSecurities Stock Issued During Period, Value, Conversion of Convertible Securities USD 111.72M 2018-01-01 2018-12-31 2018 FY 10-K 2019-03-13 0001564590-19-007458
us-gaap StockIssuedDuringPeriodValueNewIssues Stock Issued During Period, Value, New Issues USD 2,000 2024-01-01 2024-03-31 2024 Q3 10-Q 2024-11-14 0000950170-24-127139
us-gaap StockIssuedDuringPeriodValueStockOptionsExercised Stock Issued During Period, Value, Stock Options Exercised USD 19,000 2020-01-01 2020-12-31 2021 FY 10-K 2022-03-31 0001564590-22-012778
us-gaap TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests Temporary Equity, Carrying Amount, Including Portion Attributable to Noncontrolling Interests USD 111.72M 2017-12-31 2018 FY 10-K 2019-03-13 0001564590-19-007458
us-gaap TemporaryEquityDividendsAdjustment Temporary Equity, Dividends, Adjustment USD -1.59M 2018-01-01 2018-06-30 2019 Q2 10-Q 2019-08-14 0001564590-19-031978
us-gaap TemporaryEquityLiquidationPreference Temporary Equity, Liquidation Preference USD 0 2018-12-31 2018 FY 10-K 2019-03-13 0001564590-19-007458
us-gaap TemporaryEquityParOrStatedValuePerShare Temporary Equity, Par or Stated Value Per Share USD/shares 0.001 2018-12-31 2018 FY 10-K 2019-03-13 0001564590-19-007458
us-gaap TemporaryEquitySharesAuthorized Temporary Equity, Shares Authorized shares 0 2018-12-31 2018 FY 10-K 2019-03-13 0001564590-19-007458
us-gaap TemporaryEquitySharesIssued Temporary Equity, Shares Issued shares 0 2018-12-31 2018 FY 10-K 2019-03-13 0001564590-19-007458
us-gaap TemporaryEquitySharesOutstanding Temporary Equity, Shares Outstanding shares 0 2018-12-31 2018 FY 10-K 2019-03-13 0001564590-19-007458
us-gaap TreasuryStockCommonShares Treasury Stock, Common, Shares shares 5 2024-12-31 2024 FY 10-K 2025-04-15 0000950170-25-054318
us-gaap TreasuryStockPreferredShares Treasury Stock, Preferred, Shares shares 0 2018-12-31 2018 FY 10-K 2019-03-13 0001564590-19-007458
us-gaap TreasuryStockSharesAcquired Treasury Stock, Shares, Acquired shares 0 2024-01-01 2024-12-31 2024 FY 10-K 2025-04-15 0000950170-25-054318
us-gaap TreasuryStockValue Treasury Stock, Value USD 11,000 2024-12-31 2024 FY 10-K 2025-04-15 0000950170-25-054318
us-gaap UnrealizedGainLossOnDerivatives Unrealized Gain (Loss) on Derivatives USD -95,000 2024-01-01 2024-12-31 2024 FY 10-K 2025-04-15 0000950170-25-054318
us-gaap UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate Unrecognized Tax Benefits that Would Impact Effective Tax Rate USD 0 2024-12-31 2024 FY 10-K 2025-04-15 0000950170-25-054318
us-gaap ValuationAllowanceDeferredTaxAssetChangeInAmount Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount USD 6.00M 2024-01-01 2024-12-31 2024 FY 10-K 2025-04-15 0000950170-25-054318
us-gaap WeightedAverageNumberOfDilutedSharesOutstanding Weighted Average Number of Shares Outstanding, Diluted shares 2.10M 2024-01-01 2024-12-31 2024 FY 10-K 2025-04-15 0000950170-25-054318
us-gaap WeightedAverageNumberOfShareOutstandingBasicAndDiluted Weighted Average Number of Shares Outstanding, Basic and Diluted shares 38.76M 2022-01-01 2022-03-31 2022 Q1 10-Q 2022-05-16 0001564590-22-020252
us-gaap WeightedAverageNumberOfSharesOutstandingBasic Weighted Average Number of Shares Outstanding, Basic shares 2.10M 2024-01-01 2024-12-31 2024 FY 10-K 2025-04-15 0000950170-25-054318

Financialist News Desk

Our desk turns official SEC filings into news. Each story is checked against the original filing. About us → · Editorial standards →